Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: A preliminary study

Bun Hee Lee, Jin Pyo Hong, Jung A. Hwang, Kyoung Sae Na, Won Joong Kim, Jose Trigo, Yong Ku Kim

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Some clinical studies have reported reduced peripheral glial cell line-derived neurotrophic factor (GDNF) level in elderly patients with major depressive disorder (MDD). We verified whether a reduction in plasma GDNF level was associated with MDD. Method: Plasma GDNF level was measured in 23 healthy control subjects and 23 MDD patients before and after 6 weeks of treatment. Results: Plasma GDNF level in MDD patients at baseline did not differ from that in healthy controls. Plasma GDNF in MDD patients did not differ significantly from baseline to the end of treatment. GDNF level was significantly lower in recurrent-episode MDD patients than in first-episode patients before and after treatment. Conclusions: Our findings revealed significantly lower plasma GDNF level in recurrent-episode MDD patients, although plasma GDNF levels in MDD patients and healthy controls did not differ significantly. The discrepancy between our study and previous studies might arise from differences in the recurrence of depression or the ages of the MDD patients.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalActa Neuropsychiatrica
Volume28
Issue number1
DOIs
Publication statusPublished - 2015 Apr 16

Fingerprint

Glial Cell Line-Derived Neurotrophic Factor
Major Depressive Disorder
Healthy Volunteers
Therapeutics
Depression
Recurrence

Keywords

  • affective disorder
  • glial cell line-derived neurotrophic factor
  • major depressive disorder
  • protein analysis

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder : A preliminary study. / Lee, Bun Hee; Hong, Jin Pyo; Hwang, Jung A.; Na, Kyoung Sae; Kim, Won Joong; Trigo, Jose; Kim, Yong Ku.

In: Acta Neuropsychiatrica, Vol. 28, No. 1, 16.04.2015, p. 45-50.

Research output: Contribution to journalArticle

Lee, Bun Hee ; Hong, Jin Pyo ; Hwang, Jung A. ; Na, Kyoung Sae ; Kim, Won Joong ; Trigo, Jose ; Kim, Yong Ku. / Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder : A preliminary study. In: Acta Neuropsychiatrica. 2015 ; Vol. 28, No. 1. pp. 45-50.
@article{bb5c5e5628c34603ab62f1e7ac06f726,
title = "Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: A preliminary study",
abstract = "Background: Some clinical studies have reported reduced peripheral glial cell line-derived neurotrophic factor (GDNF) level in elderly patients with major depressive disorder (MDD). We verified whether a reduction in plasma GDNF level was associated with MDD. Method: Plasma GDNF level was measured in 23 healthy control subjects and 23 MDD patients before and after 6 weeks of treatment. Results: Plasma GDNF level in MDD patients at baseline did not differ from that in healthy controls. Plasma GDNF in MDD patients did not differ significantly from baseline to the end of treatment. GDNF level was significantly lower in recurrent-episode MDD patients than in first-episode patients before and after treatment. Conclusions: Our findings revealed significantly lower plasma GDNF level in recurrent-episode MDD patients, although plasma GDNF levels in MDD patients and healthy controls did not differ significantly. The discrepancy between our study and previous studies might arise from differences in the recurrence of depression or the ages of the MDD patients.",
keywords = "affective disorder, glial cell line-derived neurotrophic factor, major depressive disorder, protein analysis",
author = "Lee, {Bun Hee} and Hong, {Jin Pyo} and Hwang, {Jung A.} and Na, {Kyoung Sae} and Kim, {Won Joong} and Jose Trigo and Kim, {Yong Ku}",
year = "2015",
month = "4",
day = "16",
doi = "10.1017/neu.2015.42",
language = "English",
volume = "28",
pages = "45--50",
journal = "Acta Neuropsychiatrica",
issn = "0924-2708",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder

T2 - A preliminary study

AU - Lee, Bun Hee

AU - Hong, Jin Pyo

AU - Hwang, Jung A.

AU - Na, Kyoung Sae

AU - Kim, Won Joong

AU - Trigo, Jose

AU - Kim, Yong Ku

PY - 2015/4/16

Y1 - 2015/4/16

N2 - Background: Some clinical studies have reported reduced peripheral glial cell line-derived neurotrophic factor (GDNF) level in elderly patients with major depressive disorder (MDD). We verified whether a reduction in plasma GDNF level was associated with MDD. Method: Plasma GDNF level was measured in 23 healthy control subjects and 23 MDD patients before and after 6 weeks of treatment. Results: Plasma GDNF level in MDD patients at baseline did not differ from that in healthy controls. Plasma GDNF in MDD patients did not differ significantly from baseline to the end of treatment. GDNF level was significantly lower in recurrent-episode MDD patients than in first-episode patients before and after treatment. Conclusions: Our findings revealed significantly lower plasma GDNF level in recurrent-episode MDD patients, although plasma GDNF levels in MDD patients and healthy controls did not differ significantly. The discrepancy between our study and previous studies might arise from differences in the recurrence of depression or the ages of the MDD patients.

AB - Background: Some clinical studies have reported reduced peripheral glial cell line-derived neurotrophic factor (GDNF) level in elderly patients with major depressive disorder (MDD). We verified whether a reduction in plasma GDNF level was associated with MDD. Method: Plasma GDNF level was measured in 23 healthy control subjects and 23 MDD patients before and after 6 weeks of treatment. Results: Plasma GDNF level in MDD patients at baseline did not differ from that in healthy controls. Plasma GDNF in MDD patients did not differ significantly from baseline to the end of treatment. GDNF level was significantly lower in recurrent-episode MDD patients than in first-episode patients before and after treatment. Conclusions: Our findings revealed significantly lower plasma GDNF level in recurrent-episode MDD patients, although plasma GDNF levels in MDD patients and healthy controls did not differ significantly. The discrepancy between our study and previous studies might arise from differences in the recurrence of depression or the ages of the MDD patients.

KW - affective disorder

KW - glial cell line-derived neurotrophic factor

KW - major depressive disorder

KW - protein analysis

UR - http://www.scopus.com/inward/record.url?scp=84952872350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952872350&partnerID=8YFLogxK

U2 - 10.1017/neu.2015.42

DO - 10.1017/neu.2015.42

M3 - Article

C2 - 26122261

AN - SCOPUS:84952872350

VL - 28

SP - 45

EP - 50

JO - Acta Neuropsychiatrica

JF - Acta Neuropsychiatrica

SN - 0924-2708

IS - 1

ER -